GlassScriptPhysician profile
Leah Joseph
NPI 1629366562
$8,262.57
in general payments reported to CMS, 2019-2025
45 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,155 · 2020: $2,166 · 2021: $2,406 · 2022: $82.25 · 2023: $947 · 2024: $79.12 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Food and Beverage | $652.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,536.11 | 2019-2025 | Wegovy |
| Teladoc Health, INC. | $800.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $532.95 | 2019-2021 | |
| Allergan, INC. | $453.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $366.92 | 2019-2021 | |
| Abbvie INC. | $356.88 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $310.74 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $307.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $301.16 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $291.51 | 2019-2021 | |
| Amgen INC. | $287.14 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $287.13 | 2019-2021 | |
| Lilly USA, LLC | $242.21 | 2019-2021 | |
| Amarin Pharma, INC. | $219.74 | 2019-2021 | |
| Eisai INC. | $216.65 | 2020-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.